Skip to content

Effect of Periodontal Treatment on Adipokine Levels

Effect of Non-Surgical Periodontal Treatment on Adipokine Levels in Diabetes Mellitus: A Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06225154
Enrollment
80
Registered
2024-01-25
Start date
2015-02-28
Completion date
2016-11-30
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Periodontitis

Keywords

adipokines, diabetes mellitus, inflammation, periodontitis

Brief summary

The present study aimed to determine the effect of non-surgical periodontal treatment (NSPT) on serum and salivary adipokine and interleukin-1β levels in periodontitis patients with or without type 2 Diabetes Mellitus (T2DM).

Detailed description

The present study aimed to determine the effect of non-surgical periodontal treatment (NSPT) on serum and salivary adipokine and interleukin (IL)-1β levels in periodontitis patients with or without type 2 Diabetes Mellitus (T2DM). A total of 80 patients; 20 healthy, 20 T2DM with periodontitis (P), 20 T2DM periodontally healthy, 20 systemically healthy with P were included in this study. At baseline, serum and saliva samples were collected and the whole mouth clinical periodontal parameters were recorded. Periodontitis patients received NSPT in 4 sessions. Clinical parameters were re-measured and samples were re-collected at 1 and 3 months after treatment. Serum and salivary levels of adipokines and IL-1β were analyzed using a flow cytometry-based technique of Lumina® map™. Data were analyzed using appropriate statistical tests.

Interventions

PROCEDURENon-surgical periodontal treatment

Non-surgical periodontal treatment was performed in a quadrant-wise manner at 1-week intervals.

Sponsors

University of Turku
CollaboratorOTHER
Marmara University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Diabetes mellitus should be diagnosed for ≥1 year and HbA1c level should be at least %6,5 * Periodontitis should be diagnosed for at least 4 teeth with probing depth ≥5 mm with bleeding on probing (BOP) and also radiographic alveolar bone loss should be presence * Presence of at least 15 teeth

Exclusion criteria

* Received antibiotic treatment in the previous 3 months * Smokers * Pregnancy and lactation * Received periodontal treatment in the previous 6 months * Presence of less than 15 teeth * Having major diabetic complications

Design outcomes

Primary

MeasureTime frameDescription
Serum and Salivary Resistin Levels (pg/ml)Change between baseline, 1 and 3 months after non-surgical periodontal treatmentSerum and salivary resistin levels
Serum and saliva IL-1β levels (pg/ml)Change baseline, 1 and 3 months after non-surgical periodontal treatmentSerum and salivary IL-1β levels
Serum and Salivary Visfatin Levels (pg/ml)Change baseline, 1 and 3 months after non-surgical periodontal treatmentSerum and salivary visfatin levels
Serum and Salivary Leptin Levels (pg/ml)Change baseline, 1 and 3 months after non-surgical periodontal treatmentSerum and salivary leptin levels

Secondary

MeasureTime frameDescription
HbA1c ( %)Change baseline, 1 and 3 months after non-surgical periodontal treatmentGlycated Hemoglobin Level %

Other

MeasureTime frameDescription
Probing Depth (mm)Change baseline, 1 and 3 months after non-surgical periodontal treatmentprobing depth measured from the gingival margin seldom corresponds to sulcus or pocket depth in mm.
Clinical Attachment Level (mm)Change baseline, 1 and 3 months after non-surgical periodontal treatmentThe estimated position of structures that support the tooth as measured with a periodontal probe in mm; provides an estimate of a tooth's stability and of loss of bone support.
Bleeding on Probing (%)Change baseline, 1 and 3 months after non-surgical periodontal treatmentPercentage of bleeding sites. Bleeding on probing, often abbreviated BOP, is a sign of inflammation and indicates some sort of destruction and erosion to the lining of the sulcus or the ulceration of sulcular epithelium. The blood comes from lamina propria after the ulceration of the lining.
Gingival IndexChange baseline, 1 and 3 months after non-surgical periodontal treatmentA measure of periodontal disease based on the severity and location of the lesion. Values 0,1,2 and 3 can be taken. While 0 indicates the least value, 3 indicates the maximum value.
Plaque IndexChange baseline, 1 and 3 months after non-surgical periodontal treatmentThe measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Values 0,1,2 and 3 can be taken. While 0 indicates the least value, 3 indicates the maximum value.

Countries

Finland, Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026